Comparing Hikma Pharmaceuticals & Tate & Lyle

This page explains how Hikma Pharmaceuticals compares with Tate & Lyle

In terms of market cap, Hikma Pharmaceuticals is 1.65 times greater than Tate & Lyle, and each share in Hikma Pharmaceuticals is the equivalent to 3.04 shares in Tate & Lyle.

  HIK   TATE
Price 1,989.00+1,323.50665.50
Change -39.00 (-1.92%)-1.62-2.00 (-0.3%)
Spread 2.00 (0.101%)+0.0250.50 (0.075%)
Currency GBX GBX
Sector Medicine and Biotech Food Products
Indices UK All-Share, UK 350 , UK 100 UK All-Share, UK 250, UK 350
Hikma Pharmaceuticals Intraday Chart
Tate & Lyle Intraday Chart
Hikma Pharmaceuticals 3 Month Chart
Tate & Lyle 3 Month Chart
What if I invested £1,000?
1 month ago 1 year ago
HIK.LN/A N/A N/A N/A N/A
TATE.LN/A N/A N/A N/A N/A
  HIK   TATE
Shares in Issue 221,885,259   401,703,936
Market Capitalisation £4,413,297,802   £2,673,339,694
52 Week High 2,222.00   817.00
52 Week Low 1,711.00   587.00